Mokrov GV - Search Results

1

The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship.

Gudasheva TA, Deeva OA, Pantileev AS, Mokrov GV, Rybina IV, Yarkova MA, Seredenin SB. Gudasheva TA, et al. Among authors: mokrov gv. Molecules. 2020 Nov 4;25(21):5132. doi: 10.3390/molecules25215132. Molecules. 2020. PMID: 33158242 Free PMC article.

2

Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides.

Mokrov GV, Deeva OA, Gudasheva TA, Yarkov SA, Yarkova MA, Seredenin SB. Mokrov GV, et al. Bioorg Med Chem. 2015 Jul 1;23(13):3368-78. doi: 10.1016/j.bmc.2015.04.049. Epub 2015 Apr 23. Bioorg Med Chem. 2015. PMID: 25937237

3

The first dipeptide ligand of translocator protein: Design and anxiolytic activity.

Gudasheva TA, Deeva OA, Mokrov GV, Yarkov SA, Yarkova MA, Seredenin SB. Gudasheva TA, et al. Among authors: mokrov gv. Dokl Biochem Biophys. 2015;464:290-3. doi: 10.1134/S1607672915050063. Epub 2015 Oct 31. Dokl Biochem Biophys. 2015. PMID: 26518550

4

[PHARMACOLOGICAL STUDY OF NEW COMPOUNDS ACTING AS REGULATORS OF 18-KDA TRANSLOCATOR PROTEIN LIGANDS].

Yarkov SA, Mokrov GV, Gudasheva TA, Yarkova MA, Seredenin SB. Yarkov SA, et al. Among authors: mokrov gv. Eksp Klin Farmakol. 2016;79(1):7-11. Eksp Klin Farmakol. 2016. PMID: 27159950 Russian.

5

Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.

Gudasheva TA, Deeva OA, Mokrov GV, Dyabina AS, Yarkova MA, Seredenin SB. Gudasheva TA, et al. Among authors: mokrov gv. Med Chem. 2019;15(4):383-399. doi: 10.2174/1573406415666181119164846. Med Chem. 2019. PMID: 30457052

6

Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction.

Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, Kryzhanovskii SA. Barchukov VV, et al. Among authors: mokrov gv. Bull Exp Biol Med. 2019 Aug;167(4):460-463. doi: 10.1007/s10517-019-04549-2. Epub 2019 Sep 6. Bull Exp Biol Med. 2019. PMID: 31493255

7

Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)amino]phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction.

Kryzhanovskii SA, Ionova EO, Stolyaruk VN, Tsorin IB, Vititnova MB, Grigorkevich OS, Mokrov GV, Gudasheva TA. Kryzhanovskii SA, et al. Among authors: mokrov gv. Bull Exp Biol Med. 2020 Mar;168(5):641-645. doi: 10.1007/s10517-020-04770-4. Epub 2020 Apr 4. Bull Exp Biol Med. 2020. PMID: 32246374

8

The Ligands of Translocator Protein: Design and Biological Properties.

Mokrov GV, Deeva OA, Gudasheva TA. Mokrov GV, et al. Curr Pharm Des. 2021;27(2):217-237. doi: 10.2174/1381612826666200903122025. Curr Pharm Des. 2021. PMID: 32881658 Review.

9

Experimental Evaluation of Anxiolytic and Analgesic Properties of a New Linear Methoxyphenyltriazaalkane Derivative with Cardiotropic Activity.

Kolik LG, Nadorova AV, Tsorin IB, Barchukov VV, Mokrov GV, Likhosherstov AM, Gudasheva TA, Kryzhanovskii SA, Durnev AD. Kolik LG, et al. Among authors: mokrov gv. Bull Exp Biol Med. 2021 Apr;170(6):763-768. doi: 10.1007/s10517-021-05149-9. Epub 2021 Apr 24. Bull Exp Biol Med. 2021. PMID: 33893960

10

Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands.

Mokrov G, Pantileev A, Yarkova M, Gudasheva T, Seredenin S. Mokrov G, et al. Med Chem. 2022;18(4):497-508. doi: 10.2174/1573406417666210806095051. Med Chem. 2022. PMID: 34365957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters